Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

Matthew J Maurer, Lasse H. Jakobsen, Norbert Schmitz, Umar Farooq, Christopher R. Flowers Flowers, Peter de Nully Brown, Carrie A Thompson, Henrik Frederiksen, David Cunningham, Judit M Jørgensen, Viola Poeschel, Grzegorz S. Nowakowski, John Francis Seymour, Francesco Francesco Merl Francesco Merli, Corinne Haioun, Herve Ghesquieres, Marita Ziepert, Hervé Tilly, Gilles Andre Salles, Qiang ShiTarec Christoffer El-Galaly, Thomas M. Habermann

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer400
TidsskriftBlood
Vol/bind134
Udgave nummerSupplement 1
ISSN0006-4971
DOI
StatusUdgivet - 13. nov. 2020
BegivenhedAmerican Society of Hematology: 61st Annual Meeting (ASH) - Orlando, USA
Varighed: 7. dec. 201910. dec. 2019

Konference

KonferenceAmerican Society of Hematology: 61st Annual Meeting (ASH)
LandUSA
ByOrlando
Periode07/12/201910/12/2019

Citationsformater